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Abstract
Objective: An estimated 1.1 million people are living with the human immunodeficiency virus
(HIV) in the United States. Despite over two decades of research, a cure for HIV has not been
approved and it remains a pandemic. This research study was conducted to determine the
statistical significance in HIV incidence based on diagnoses in 2008 versus 2018; age groups 2534 years old versus 55+ years old; Black versus Hispanic versus White; male versus female; and
geographical location. Methods: This retrospective study was conducted using data from the
Center for Disease Control and Prevention (CDC) Atlas Plus data sets, a collection of
surveillance data from previous years. Analysis was done using paired t-test for prevalence
comparison by year and unpaired t-test for age and sex. ANOVA test was used to compare
prevalence by race. Descriptive analysis was done using z-scores to determine differences in
HIV rates by state. Results: Incidence by rate from 2008 versus 2018 using a 2-tailed t-test
resulted as t50=1.99, P=.052 indicating no statistical significance in incidence in comparison.
Analysis of incidence in age groups 25-34 versus 55+ resulted as t50=9.69, P<.001, indicating a
statistical significance. Analysis of incidence by race resulted as F2,150=46.23, P<.001, indicating
a statistically significant difference between races. Analysis of incidence by sex resulted as
t50=7.80, P<.001, indicating a statistically significance difference between males and females.
Analysis of incidence in states using descriptive analysis resulted as mean 10.67 (SD 7.21).
Outliers include District of Columbia with z-score 3.32 and southern states Florida, Georgia, and
Louisiana with z-score 2.07, 2.57,and 2.06 respectively.
Key Words: HIV; prevalence; incidence; surveillance
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Introduction
Since the first case of confirmed human immunodeficiency virus (HIV) in 19591 and its
recognition in 1981 as an infectious disease, biomedical and scientific research advances have
led to successful treatment regimens, prevention strategies, and improved care for persons living
with this once fatal disease. Although knowledge and treatment options have expanded with
exposure prophylaxis, HIV incidence and prevalence remain high worldwide. With an estimated
1 million people living with the disease in the United States and over two decades of research,
surprisingly there is still not an approved cure for HIV leading to an ongoing pandemic.2 In
2018, 37,832 people received a diagnosis of HIV in the United States and dependent areas. 69%
were among men who have sex with men, 24% among heterosexuals, and 7% among IV drug
users. The highest incidence by age was in the 24-34 age group with 13,458 new diagnoses.
Blacks accounted for the highest percentage by race of new cases (42%), Hispanic/Latinos
(27%), Whites (25%). Regionally, the highest diagnosis rate (per 100,000 people) was in the
South (15.7) and the least in the Midwest (7.2).3
Fortunately, the incidence of HIV infection has declined in the United States since the
implementation of the National HIV/AIDS Strategy in 2010.4 The vision of the National
HIV/AIDS Strategy is for HIV incidence to be low in the United States. It states that every
person regardless of age, gender, race/ethnicity, sexual orientation, gender identity or socioeconomic circumstance will have quality care without humiliation.5 In 2019, the United States
Department of Health and Human Services (HHS) proposed a new initiative to reduce incidence
in the United States by up to ninety percent in ten years. The initiative key strategies include
diagnosing HIV infections rapidly after acquisition; treating effectively to sustain decreased to
undetectable viral load; protecting high-risk populations with prophylactic treatments; and
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recognizing and responding to geographical areas with high incidence to prevent transmission.2
To implement such an initiative, it is important to recognize trends in HIV prevalence and
incidence.
This research study was conducted using data from the Center for Disease Control and
Prevention (CDC) to determine the statistical significance in HIV incidence based on year of
diagnosis, age, race, sex, and geographical location. At the time of this research, no other studies
were found that looked at this data for the aforementioned variables.
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Hypothesis/Specific Aims/Research Questions
Research questions:
1. Is the HIV diagnosis rate significantly different in all races and both sexes ages 13 years and
older from reported cases in 2008 compared to 2018?
2. Is the HIV diagnosis rate significantly different in all races and both sexes in age groups 2534 compared to age 55+?
3. Is the HIV diagnosis rate significantly different in both sexes, ages 13 years and older across
races (Blacks, Hispanics, Whites)?
4. Is the HIV diagnosis rate significantly different in all races ages 13 years and older across
gender?
5. Is the HIV diagnosis rate significantly different in all races and both sexes ages 13 years and
older in the different states within the United States?
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Methods
Data Collection
To answer the research questions, data was taken from the Center for Disease Control and
Prevention (CDC) Atlas Plus data sets. These data sets are collections of surveillance data
collected by the CDC from more than 15 years.6 The data sets included are
a. HIV diagnoses | 2008-2018 | Ages 13 years and older | All races/ethnicities | Both
sexes | All transmission categories | By State
b. HIV diagnoses | 2018 | Ages 13 years and older | All races/ethnicities | Both sexes |
All transmission categories | By State
Data points for American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and U.S. Virgin
Islands were excluded from this analysis.
Data Analysis
All analysis was completed using IBM SPSS Statistics v. 26 software.
RQ1: Is the HIV diagnosis rate significantly different in all races and both sexes ages 13 years
and older from reported cases in 2008 compared to 2018?
Analysis by paired t-test by state of HIV prevalence in 2008 versus 2018.
RQ2: Is the HIV diagnosis rate significantly different in all races and both sexes in age group 2534 compared to age 55+?
Analysis by unpaired t-test by state of HIV prevalence in age group 25-34 versus 55+.
RQ3: Is the HIV diagnosis rate significantly different in both sexes, ages 13 years and older in
across races (Blacks, Hispanics, Whites)?
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Analysis by ANOVA by state of HIV prevalence in Blacks versus Hispanics versus Whites.
RQ4: Is the HIV diagnosis rate significantly different in all races ages 13 years and older across
gender?
Analysis by unpaired t-test by state of HIV prevalence in males versus females.
RQ5: Is the HIV diagnosis rate significantly different in all races and both sexes ages 13 years
and older in the different states within the United States and the dependent areas?
Analysis by descriptive statistics using z-scores to determine difference in HIV diagnosis rate
between states.

Gardner 8
Results
On analysis, race, age, and sex were associated with statistical significance in rate of
incidence difference (P<.001 for all categories). The rate of incidence was not significant
between years 2008 and 2018 (P=.052) with a mean rate of incidence of 17.22 and 10.67 in 2008
and 2018, respectively. A summary of all analyses is outlined in the Table.
Table: Mean Rate of Incidence of HIV in the United States and Washington, D.C
n

Mean Rate

SD

P value
.052

Year
2008

51

17.22

28.14

2018

51

10.67

7.21
<.001a

Age (in years)
25-34

51

22.65

14.12

55+

51

3.16

2.65
<.001a

Race
Black

51

39.69

17.25

Hispanic

51

19.58

26.68

White

51

4.80

2.42
<.001a

Sex
Male

51

17.52

11.81

Female

51

4.15

3.24

Abbreviations: n, sample size; SD, Standard Deviation; sstatistical significance
Analysis of RQ1-4 are summarized in this table. RQ1 (year): No significant difference between
2008 and 2018 (t = 1.99, P= .052); Paired t-test. RQ2 (age): Significant difference between age
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groups 25-34 and 55+ (t = 9.69, P < .001); Unpaired t-test. RQ3 (race): Significant difference
between Black, Hispanic, and White individuals (F = 46.27, P < .001); ANOVA. RQ4 (sex):
Significant difference between males and females (t = 7.797, P < .001); Unpaired t-test.
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Discussion
Analysis of HIV rate of incidence in 2008 compared to 2018 in the United States resulted
in P=0.052 which is not significant. The mean rate in 2008 was 17.21 (SD 28.14) and in 2018
was 10.67 (SD 7.21). Although the data rate of change is not significantly different there has
been consistent decrease in the number of new cases of HIV since 2008, most specifically in
areas with higher incidence and prevalence of HIV. The rate of incidence in the District of
Columbia, which has the highest rate of incidence, decreased by 168% from 2008 to 2018. The
Southern states, specifically Florida and Georgia, which contribute the greatest number of HIV
new cases annually saw a decrease of 11.6% and 11.1%, respectively.
Analysis of 2018 rate of incidence in age groups 25-34 versus 55+ resulted as t50=9.69,
P<.001, indicating a statistically significance between age groups which is consistent with
published data.3 The mean rate of incidence per 100,000 people was 22.65 and 3.16 in the 25-34
and the 55+ year old age groups, respectively. This indicates a vast difference in rate of new
cases in comparison. In recent years, there has been a decline in incidence in the age group less
than 25 years of age7 which previously was the group with the highest incidence of HIV.
Incidence is now highest in the 25-34 age group with an estimated 13,500 new cases in 2018. A
potential cause for this documented increase in this age group is increased availability of HIV
testing and use of pharmaceuticals that prevent transmission of the virus. Drugs like Truvada,
approved in 2012 by the Food and Drug Administration, have been shown to reduce the relative
risk of acquisition of HIV if taken daily with the use of safer sex practices.8 To be eligible for
such therapeutics, patients must test negative for the virus which increase testing numbers and
ultimately identify more patients who test positive. Individuals at increased risk of becoming
HIV positive can now take such drugs at an early age to significantly decrease those risks.
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People in the 25-34 age group are being tested more frequently leading to an increase in known
incidence in this age range. The 13-24 age group with less exposure to high risk practices has,
again, shown a decrease in incidence likely because of such interventions. New cases over the
age of 55 have consistently been the lowest of all age groups. New number of new cases in this
group were an estimated 3,900 in 2018.7
Analysis of 2018 rate of incidence in Blacks, Hispanics, and Whites resulted as F2,150=46.23,
P<.001, indicating a statistically significant difference between ethnic groups. Blacks and
Hispanics are disproportionally affected at higher rates in comparison to Whites. The rate of
incidence was 39.69 for Blacks; 19.58 for Hispanics; and 4.80 for Whites. Overall, blacks had
the highest incidence with an estimated 16,000 new cases in 2018.3 The higher number of cases
in Blacks and Hispanics is thought to be due to lower socioeconomic status and perceived stigma
towards the healthcare community. Blacks and Hispanics also have decreased access to
healthcare which decreases testing availability and adequate management if the virus is acquired.
69% of new cases of HIV in 2018 were attributed to men who has sex with men (MSM)7, with
the highest proportion being in the Black community. A study from Northwestern University
concluded that although the number of new cases of HIV is roughly 16 times higher in Black
men who engage in MSM behaviors versus their white counterparts, their high-risk behaviors are
less.9 Blacks reports higher testing rates and lower unsafe sexual practices; however, they have a
more socially connected network which increases their chances of acquiring the disease
epidemiologically. Other identified findings that attribute to the disparities between races include
Blacks have a higher prevalence of HIV and levels of trauma, childhood abuse, and
victimization.9-10
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Analysis of rate of incidence in males versus females resulted as t50=7.80, P<.001, indicating
a statistically significance between males and females. Rate of incidence was 17.52 in men and
4.15 in women. The number of new cases is an estimated 30,521 and 7,179 in men and women3,
respectively according to the CDC. The highest incidence of HIV was through MSM sexual
contact, as discussed above, which has been consistent with data from past years. Incidence has
been decreasing in women since 2010 with a decline of 24% in 2018. Of the new cases in
women, 85% were acquired through heterosexual sexual contact.6
Analysis of rate of incidence in states using descriptive analysis resulted as mean 10.67 (SD
7.21). District of Columbia was an outlier with z-score 3.32 and southern states Florida, Georgia,
and Louisiana with z-score 2.07, 2.57,and 2.06 respectively were greatly different from the other
states. This data is consistent with published data. The highest incidence of HIV by region,
accounting for greater than half of the cases3, is the Southern region inclusive of Florida,
Georgia, and Louisiana but interestingly only about 35% of the population lives in this region.
The rate of incidence for these states are 25.6 (Florida), 29.2, (Georgia) and 25.5 (Louisiana).
Factors that lead to the great propensity of acquiring HIV in the South in comparison to other
regions have been noted as poverty and unemployment; a decreased uptake in the use of preexposure prophylaxis; and decreased health insurance. Stigma is also highly prevalent in
Southern states around sexual orientation, substance use disorders, and poverty which leads to a
decrease in affected populations seeking prevention and treatment.10 The District of Columbia
has the highest number of cases per 100,000 people with a rate of 34.6 whereas Maine had the
lowest rate at 2.4. The District of Columbia has consistently had the highest number of new cases
of HIV yearly for decades. However, with the efforts such as the End the HIV Epidemic in DC
2020, the number of new cases is now decreasing at about 4% annually.11
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Conclusion
Great strides have been made to decrease incidence of HIV worldwide but with numbers
exceeding 35,000 annually and a prevalence of more than 1.1 million people living in the U.S.,2
it is evident that more work is needed. A key error that should be targeted is access to quality
care including testing, antiretroviral therapy, and sustained follow-up to with primary care
providers to ensure proper education and compliance. Studies have shown that retention and
reengagement with health care professionals is vital in the efforts to decrease HIV and AIDS in
all populations.12
As evident by the evidence presented in this review, disparities exist in HIV/AIDS
screenings, diagnoses, and treatment as Blacks and Hispanics are significantly more likely to be
diagnosed when compared to Whites. This is linked to a decrease in access to care in these
vulnerable populations as well as a decrease in health literacy, socioeconomic status, and a
general mistrust of the healthcare system.9 As infectious disease research moves forward, it is
important to include minorities in studies and trials to close the gap that exists leading to
inequities and inequalities. Fortunately, with the onset of prevention strategies, the number of
new cases is continuing to slowly decline annually with the hope of no transmission of the virus
and ultimately a cure.
This population study research was limited by estimated numbers from the CDC database.
This research may be continued by stratifying the rate of new cases by availability of resources
by states and communities. Inclusion of new data from beyond 2018 should also be studied to
follow trends in incidence, geographic location, age , and ethnicity. Prevalence should also be
added to this study as people are living normal lifespans with increasing understanding of
HIVand the use of pharmaceuticals to increase prevention and decrease transmission.
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